Article | February 1, 2023

Defining Pharmacovigilance And Reviewing Its History

Source: Verista
Drug Safety GettyImages-1265108955

Pharmacovigilance (PV) is defined by the World Health Organization (WHO) as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem. PV focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy.

Ultimately, PV is concerned with identifying the hazards associated with pharmaceutical products and with minimizing the risk of any harm that may come to patients. Sounds simple enough, but the process that pharmaceutical companies go through to satisfy this requirement is rather complex.

Learn about Pharmacovigilance, a brief history of PV, and more.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online